Clinical Trial Update: Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by the National Cancer Institute evaluating maintenance therapy for extensive-stage small cell lung cancer in SLFN11-positive p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Lung Small Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING